SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent

3,4,5
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML

Data provided by Kaleidoscope.